Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical Officer

AFMD Stock  USD 2.84  0.03  1.05%   
About 62% of Affimed NV's investor base is looking to short. The analysis of the overall investor sentiment regarding Affimed NV suggests that many traders are alarmed. The current market sentiment, together with Affimed NV's historical and current headlines, can help investors time the market. In addition, many technical investors use Affimed NV stock news signals to limit their universe of possible portfolio assets.
  
Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical Officer Newly established role at Essential Pharma further strengthens leadership team and supports global growth Dr Liz Holmes rare disease and oncology expertise to be instrumental in bringing clinical stage immunotherapy asset Hu14.18 to market Egham, UK 16 October 2024 Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically di

Read at finance.yahoo.com
Yahoo News
  

Affimed NV Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Affimed NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Affimed NV Fundamental Analysis

We analyze Affimed NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Affimed NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Affimed NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Affimed NV is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Affimed NV Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Affimed NV stock to make a market-neutral strategy. Peer analysis of Affimed NV could also be used in its relative valuation, which is a method of valuing Affimed NV by comparing valuation metrics with similar companies.

Peers

Affimed NV Related Equities

XFORX4 Pharmaceuticals   11.43   
0%
100.0%
ADCTADC Therapeutics   7.08   
0%
61.0%
HEPAHepion Pharmaceuticals   4.69   
0%
41.0%
ELEVElevation Oncology   3.23   
0%
28.0%
LPTXLeap Therapeutics   2.05   
0%
17.0%
PDSBPDS Biotechnology   1.86   
0%
16.0%
DAWNDay One   1.53   
0%
13.0%
MREOMereo BioPharma   1.40   
0%
12.0%
INZYInozyme Pharma   0.37   
3.0%
0%
ADAPAdaptimmune Therapeutics   1.37   
11.0%
0%
TERNTerns Pharmaceuticals   1.58   
13.0%
0%
AGENAgenus   2.01   
17.0%
0%
PIRSPieris Pharmaceuticals   3.45   
30.0%
0%
CRVSCorvus Pharmaceuticals   3.50   
30.0%
0%
APTOAptose Biosciences   5.26   
46.0%
0%

Complementary Tools for Affimed Stock analysis

When running Affimed NV's price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing